3,4-Dihydroxy-5-(1,2,3-trihydroxypropyl)oxolan-2-one | 89-67-8

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 内酯类
• 英文名称: 3,4-Dihydroxy-5-(1,2,3-trihydroxypropyl)oxolan-2-one
• CAS: 89-67-8；15397-08-7；5329-44-2；60046-25-5
• 化学式: C₇H₁₂O₇
• mdl: MFCD00066664
• 分子量: 208.17
• InChiKey: VIVCRCODGMFTFY-UHFFFAOYSA-N

物化性质

• 熔点：
  152-155 °C(lit.)
• 沸点：
  557.5±30.0 °C(Predicted)
• 密度：
  1.806±0.06 g/cm3(Predicted)
• 稳定性/保质期：

  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  -2.6
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.857
• 拓扑面积：
  127
• 氢给体数：
  5
• 氢受体数：
  7

SDS

Name:	alpha-D-Glucoheptonic acid gamma lactone 99% Material Safety Data Sheet
Synonym:	None
CAS:	60046-25-5

Section 1 - Chemical Product MSDS Name:alpha-D-Glucoheptonic acid gamma lactone 99% Material Safety Data Sheet
Synonym:None

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
60046-25-5	alpha-D-Glucoheptonic acid gamma lacto	99	262-037-0

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or alcohol-resistant foam. Use agent most appropriate to extinguish fire.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 60046-25-5: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: white
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 152.00 - 155.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H12O7
Molecular Weight: 208.17

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 60046-25-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
alpha-D-Glucoheptonic acid gamma lactone - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 60046-25-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 60046-25-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 60046-25-5 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

葡庚糖酸内酯是一种酯类有机物，主要用作医药合成的中间体。

文献信息

• [EN] CHROMOBACTERIUM FORMULATIONS, COMPOSTIONS, METABOLITES AND THEIR USES<br/>[FR] FORMULATIONS, COMPOSITIONS, MÉTABOLITES DE CHROMOBACTERIUM ET LEURS UTILISATIONS
  申请人：MARRONE BIO INNOVATIONS INC

  公开号：WO2013062977A1

  公开（公告）日：2013-05-02

  Stabilized biological pesticides comprising Chromobacterium species, filtrate, supernatant, extract or pesticidally active substance derived therefrom with pesticidal activity having improved shelf life due to maintenance of physical uniformity and longer insecticide activity after use due to higher resistance to degradation when exposed to sunlight are disclosed.

  抗稳定生物农药包括染色细菌属物种、滤液、上清液、提取物或由此衍生的具有杀虫活性的农药活性物质，由于保持物理均匀性而具有改善的货架寿命，并且由于在暴露于阳光下时更高的抗降解性导致使用后具有更长的杀虫活性。
• Substituted Lactams and Their Use as Anti-Cancer Agents
  申请人：Bair Kenneth Walter

  公开号：US20080275025A1

  公开（公告）日：2008-11-06

  This invention relates to certain substituted lactam compounds, particularly caprolactam compounds, which are useful for the treatment of cancer.

  本发明涉及某些取代的内酰胺化合物，特别是己内酰胺化合物，其对于癌症的治疗是有用的。
• Bicyclic tetrahydroxylated pyrrolizidines
  申请人：MONSANTO COMPANY

  公开号：EP0417059A2

  公开（公告）日：1991-03-13

  Novel bicyclic tetrahydroxylated pyrrolizidines are disclosed which are inhibitors of glycosidase enzymes. A preferred inhibitor is 1α,2α,6α,7α,7αβ-1,2,6-7-tetrahydroxypyrroli­zidine. It is synthesized from D-glycero-D-­gulo-heptono-1,4-lactone.

  本研究公开了新型双环四羟基吡咯烷类化合物，它们是糖苷酶的抑制剂。一种优选的抑制剂是 1α,2α,6α,7α,7αβ-1,2,6-7-四羟基吡咯烷。它由 D-甘油-D-古洛-庚-1,4-内酯合成。
• Long chain glycolipids useful to avoid perishing or microbial contamination of materials
  申请人：InterMed Discovery GmbH

  公开号：EP2532232A1

  公开（公告）日：2012-12-12

  The invention relates to the use of, and methods of use employing, certain glycolipid compounds as defined in detail below and having preservative or antimicrobial properties, novel compounds of the glycolipid class, and related invention embodiments. The compounds have the formula I wherein m is 3 to 5, n is 2 to 5, o is 0 or 1 and p is 3 to 17, with the proviso that the sum m + n + o + p is not less than 14; and R is a carbohydrate moiety bound via one of its carbon atoms to the binding oxygen, and/or a physiologically, especially pharmaceutically or nutraceutically or cosmetically, acceptable salt thereof, or an ester thereof, as such or in the form of a composition, where the compound may be present in open chain form and/or in the form of a lactone (Fig. 1).

  本发明涉及下文详细定义的某些具有防腐或抗菌特性的糖脂化合物、糖脂类新型化合物以及相关发明实施例的用途和使用方法。 这些化合物具有式 I 其中 m 为 3 至 5，n 为 2 至 5，o 为 0 或 1，p 为 3 至 17，但 m + n + o + p 之和不小于 14；以及 R 是通过其一个碳原子与结合氧结合的碳水化合物分子、 和/或其生理上，特别是药学上、营养学上或化妆品上可接受的盐，或其酯、 或以组合物的形式存在、 其中化合物可以开链形式和/或内酯形式存在（图 1）。
• BEVERAGE PREPARATION CAPSULE FOR DELIVERY OF A SOLUBILISATE
  申请人：Athenion AG

  公开号：EP3216443A1

  公开（公告）日：2017-09-13

  The present invention relates to a beverage preparation capsule for the delivery of a solubilisate, a beverage dispensing system configured for the use of such a beverage preparation capsule and a method for preparing a beverage by means of such a beverage dispensing system. Poorly water-soluble dietary supplements or pharmaceutical active agents can be delivered in this new dosage form in order to increase the bioavailability of these substances.

  本发明涉及一种用于输送可溶性物质的饮料配制胶囊、一种为使用这种饮料配制胶囊而配置的饮料分配系统以及一种通过这种饮料分配系统配制饮料的方法。水溶性差的膳食补充剂或药物活性剂可以用这种新的剂型输送，以提高这些物质的生物利用率。

表征谱图